Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Ashton-Prolla

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
BMC Proceedings|April 26, 2014
Hereditary cancer syndromes: opportunities and challengesPatricia Ashton-Prolla
Genetics and Molecular Biology|June 9, 2016
The Brazilian Hereditary Cancer Network: historical aspects and challenges for clinical cancer genetics in the public health care system in BrazilPatricia Ashton-Prolla, Hector N Seuanez
Genetics and Molecular Biology|April 26, 2014
Prevalence and impact of founder mutations in hereditary breast cancer in Latin AmericaPatricia Ashton-Prolla, Fernando Regla Vargas
Biomarker Insights|December 22, 2015
miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A ReviewBárbara Alemar, Cleandra Gregório, Patricia Ashton-Prolla
Expert Review of Molecular Diagnostics|March 2, 2022
Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosisDébora Leite Rocha, Patricia Ashton-Prolla, Clévia Rosset
Genetics and Molecular Biology|May 9, 2019
Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine eraGabriel S Macedo, Barbara Alemar, Patricia Ashton-Prolla
The Lancet. Oncology|September 1, 2009
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?Maria Isabel Waddington Achatz, Pierre Hainaut, Patricia Ashton-Prolla
Genetics and Molecular Biology|February 22, 2017
TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a reviewClévia Rosset, Cristina Brinckmann Oliveira Netto, Patricia Ashton-Prolla
Plos One|January 15, 2019
TULP3: A potential biomarker in colorectal cancer?Ivaine Taís Sauthier Sartor, Mariana Recamonde-Mendoza, Patricia Ashton-Prolla
Arquivos De Gastroenterologia|August 30, 2005
Hereditary non-polipomatous colorectal cancer: hereditary predisposition, diagnosis and preventionRenata dos Santos Coura, Patricia Ashton-Prolla, João Carlos Prolla
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
BMC Proceedings|April 26, 2014
Hereditary cancer syndromes: opportunities and challengesPatricia Ashton-Prolla
Genetics and Molecular Biology|June 9, 2016
The Brazilian Hereditary Cancer Network: historical aspects and challenges for clinical cancer genetics in the public health care system in BrazilPatricia Ashton-Prolla, Hector N Seuanez
Genetics and Molecular Biology|April 26, 2014
Prevalence and impact of founder mutations in hereditary breast cancer in Latin AmericaPatricia Ashton-Prolla, Fernando Regla Vargas
Biomarker Insights|December 22, 2015
miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A ReviewBárbara Alemar, Cleandra Gregório, Patricia Ashton-Prolla
Expert Review of Molecular Diagnostics|March 2, 2022
Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosisDébora Leite Rocha, Patricia Ashton-Prolla, Clévia Rosset
Genetics and Molecular Biology|May 9, 2019
Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine eraGabriel S Macedo, Barbara Alemar, Patricia Ashton-Prolla
The Lancet. Oncology|September 1, 2009
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?Maria Isabel Waddington Achatz, Pierre Hainaut, Patricia Ashton-Prolla
Genetics and Molecular Biology|February 22, 2017
TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a reviewClévia Rosset, Cristina Brinckmann Oliveira Netto, Patricia Ashton-Prolla
Plos One|January 15, 2019
TULP3: A potential biomarker in colorectal cancer?Ivaine Taís Sauthier Sartor, Mariana Recamonde-Mendoza, Patricia Ashton-Prolla
Arquivos De Gastroenterologia|August 30, 2005
Hereditary non-polipomatous colorectal cancer: hereditary predisposition, diagnosis and preventionRenata dos Santos Coura, Patricia Ashton-Prolla, João Carlos Prolla
Pageof 14